Cargando…
Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model
BACKGROUND: Asthma is a multifactorial disease for which a variety of mouse models have been developed. A major drawback of these models is represented by the transient nature of the airway pathology peaking 24–72 h after challenge and resolving in 1–2 weeks. We characterized the temporal evolution...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619338/ https://www.ncbi.nlm.nih.gov/pubmed/26496719 http://dx.doi.org/10.1186/s12967-015-0696-5 |
_version_ | 1782397079312662528 |
---|---|
author | Stellari, Fabio Sala, Angelo Ruscitti, Francesca Carnini, Chiara Mirandola, Prisco Vitale, Marco Civelli, Maurizio Villetti, Gino |
author_facet | Stellari, Fabio Sala, Angelo Ruscitti, Francesca Carnini, Chiara Mirandola, Prisco Vitale, Marco Civelli, Maurizio Villetti, Gino |
author_sort | Stellari, Fabio |
collection | PubMed |
description | BACKGROUND: Asthma is a multifactorial disease for which a variety of mouse models have been developed. A major drawback of these models is represented by the transient nature of the airway pathology peaking 24–72 h after challenge and resolving in 1–2 weeks. We characterized the temporal evolution of pulmonary inflammation and tissue remodeling in a recently described mouse model of chronic asthma (8 week treatment with 3 allergens: Dust mite, Ragweed, and Aspergillus; DRA). METHODS: We studied the DRA model taking advantage of fluorescence molecular tomography (FMT) imaging using near-infrared probes to non-invasively evaluate lung inflammation and airway remodeling. At 4, 6, 8 or 11 weeks, cathepsin- and metalloproteinase-dependent fluorescence was evaluated in vivo. A subgroup of animals, after 4 weeks of DRA, was treated with Budesonide (100 µg/kg intranasally) daily for 4 weeks. RESULTS: Cathepsin-dependent fluorescence in DRA-sensitized mice resulted significantly increased at 6 and 8 weeks, and was markedly inhibited by budesonide. This fluorescent signal well correlated with ex vivo analysis such as bronchoalveolar lavage eosinophils and pulmonary inflammatory cell infiltration. Metalloproteinase-dependent fluorescence was significantly increased at 8 and 11 weeks, nicely correlated with collagen deposition, as evaluated histologically by Masson’s Trichrome staining, and airway epithelium hypertrophy, and was only partly inhibited by budesonide. CONCLUSIONS: FMT proved suitable for longitudinal studies to evaluate asthma progression, showing that cathepsin activity could be used to monitor inflammatory cell infiltration while metalloproteinase activity parallels airway remodeling, allowing the determination of steroid treatment efficacy in a chronic asthma model in mice. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-015-0696-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4619338 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46193382015-10-26 Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model Stellari, Fabio Sala, Angelo Ruscitti, Francesca Carnini, Chiara Mirandola, Prisco Vitale, Marco Civelli, Maurizio Villetti, Gino J Transl Med Research BACKGROUND: Asthma is a multifactorial disease for which a variety of mouse models have been developed. A major drawback of these models is represented by the transient nature of the airway pathology peaking 24–72 h after challenge and resolving in 1–2 weeks. We characterized the temporal evolution of pulmonary inflammation and tissue remodeling in a recently described mouse model of chronic asthma (8 week treatment with 3 allergens: Dust mite, Ragweed, and Aspergillus; DRA). METHODS: We studied the DRA model taking advantage of fluorescence molecular tomography (FMT) imaging using near-infrared probes to non-invasively evaluate lung inflammation and airway remodeling. At 4, 6, 8 or 11 weeks, cathepsin- and metalloproteinase-dependent fluorescence was evaluated in vivo. A subgroup of animals, after 4 weeks of DRA, was treated with Budesonide (100 µg/kg intranasally) daily for 4 weeks. RESULTS: Cathepsin-dependent fluorescence in DRA-sensitized mice resulted significantly increased at 6 and 8 weeks, and was markedly inhibited by budesonide. This fluorescent signal well correlated with ex vivo analysis such as bronchoalveolar lavage eosinophils and pulmonary inflammatory cell infiltration. Metalloproteinase-dependent fluorescence was significantly increased at 8 and 11 weeks, nicely correlated with collagen deposition, as evaluated histologically by Masson’s Trichrome staining, and airway epithelium hypertrophy, and was only partly inhibited by budesonide. CONCLUSIONS: FMT proved suitable for longitudinal studies to evaluate asthma progression, showing that cathepsin activity could be used to monitor inflammatory cell infiltration while metalloproteinase activity parallels airway remodeling, allowing the determination of steroid treatment efficacy in a chronic asthma model in mice. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-015-0696-5) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-24 /pmc/articles/PMC4619338/ /pubmed/26496719 http://dx.doi.org/10.1186/s12967-015-0696-5 Text en © Stellari et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Stellari, Fabio Sala, Angelo Ruscitti, Francesca Carnini, Chiara Mirandola, Prisco Vitale, Marco Civelli, Maurizio Villetti, Gino Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model |
title | Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model |
title_full | Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model |
title_fullStr | Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model |
title_full_unstemmed | Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model |
title_short | Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model |
title_sort | monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619338/ https://www.ncbi.nlm.nih.gov/pubmed/26496719 http://dx.doi.org/10.1186/s12967-015-0696-5 |
work_keys_str_mv | AT stellarifabio monitoringinflammationandairwayremodelingbyfluorescencemoleculartomographyinachronicasthmamodel AT salaangelo monitoringinflammationandairwayremodelingbyfluorescencemoleculartomographyinachronicasthmamodel AT ruscittifrancesca monitoringinflammationandairwayremodelingbyfluorescencemoleculartomographyinachronicasthmamodel AT carninichiara monitoringinflammationandairwayremodelingbyfluorescencemoleculartomographyinachronicasthmamodel AT mirandolaprisco monitoringinflammationandairwayremodelingbyfluorescencemoleculartomographyinachronicasthmamodel AT vitalemarco monitoringinflammationandairwayremodelingbyfluorescencemoleculartomographyinachronicasthmamodel AT civellimaurizio monitoringinflammationandairwayremodelingbyfluorescencemoleculartomographyinachronicasthmamodel AT villettigino monitoringinflammationandairwayremodelingbyfluorescencemoleculartomographyinachronicasthmamodel |